Novel drugs for medical insurance introduced

China will introduce a new category of innovative medicines to its public medical insurance system to encourage drug development.

The new Category C, with the first edition to be released this year, will focus on innovative drugs that have high clinical demand but are expensive to develop, the National Healthcare Security Administration announced Friday.